Treatment for Type 2E Limb Girdle Muscular Dystrophy Gets Rare Pediatric Drug Designation
source: pixabay.com

Treatment for Type 2E Limb Girdle Muscular Dystrophy Gets Rare Pediatric Drug Designation

According to a story from Business Wire, the gene therapy company Myonexus Therapeutics announced that the U.S. FDA has given Rare Pediatric Disease Designation for its gene therapy candidate MYO-101.…

Continue Reading Treatment for Type 2E Limb Girdle Muscular Dystrophy Gets Rare Pediatric Drug Designation
New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia
source: pixabay.com

New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia

According to a story from Cardiovascular Business, The FH Foundation, which is a frontrunning patient advocacy and research organization for familial hypercholesterolemia, recently announced that it has begun enrollment for…

Continue Reading New Study From The FH Foundation Will Investigate Genetic Testing of Familial Hypercholesterolemia
Unrest: The New Documentary about Myalgic Encephalopathy (Chronic Fatigue Syndrome)
source: pixabay.com

Unrest: The New Documentary about Myalgic Encephalopathy (Chronic Fatigue Syndrome)

A new documentary, Unrest, explores myalgic encephalopathy (ME), also known as chronic fatigue syndrome. The film was premiered at the Sundance Film Festival 2017 where it received an award for…

Continue Reading Unrest: The New Documentary about Myalgic Encephalopathy (Chronic Fatigue Syndrome)
An Experimental Drug for Duchenne Muscular Dystrophy Has Been Awarded Orphan Drug Status by the F.D.A.
Source: Pixabay

An Experimental Drug for Duchenne Muscular Dystrophy Has Been Awarded Orphan Drug Status by the F.D.A.

The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to the experimental drug Sarconeos, developed by the company Biophytis, for the treatment of Duchenne muscular dystrophy. The…

Continue Reading An Experimental Drug for Duchenne Muscular Dystrophy Has Been Awarded Orphan Drug Status by the F.D.A.
Researchers Are Investigating a New Way to Monitor Disease Progression for People with Charcot-Marie-Tooth Disease Type 1
Source: Pixabay

Researchers Are Investigating a New Way to Monitor Disease Progression for People with Charcot-Marie-Tooth Disease Type 1

Researchers have found a new way to monitor disease progression in people with Charcot-Marie-Tooth disease type 1 (CMT1), reports Charcot Marie Tooth News. CMT1 is an inherited genetic condition that…

Continue Reading Researchers Are Investigating a New Way to Monitor Disease Progression for People with Charcot-Marie-Tooth Disease Type 1